Introduction
Experience with high-risk patients has shown that continuous fetal heart rate (F.H.R.) monitoring combined, when necessary, with fetal pH measurement, is a reliable system for the early detection of intra-partum fetal asphyxia and prevention of stillbirth.' Quilligan2 in a large survey observed that the incidence of intra-partum stillbirth was about three times less in a high-risk group of patients who were monitored than the expected rate in an unmonitored group. It seemed, therefore, that a relatively simple system for monitoring the fetus was available which was safer than the traditional fetal stethoscope. These studies showed that though perinatal mortality was significantly reduced in the monitored high-risk group the unmonitored "normal" group had a significant perinatal mortality (3-7 per 1000 deliveries in the "normal" unmonitored group compared with 1-5 per 1000 in the high-risk monitored group2). Thus, it seemed logical to try to monitor all patients as soon as they were admitted in labour in an attempt to reduce the effects of intra-partum asphyxia still further. Similar attempts have been made in some units but the number of patients actually monitored was less than half those available,3 4chiefly because of the staff's unfamiliarity with or resistance to new techniques.
Our objective was to monitor as many patients as possible over two years introduced, a significant reduction in the proportion of intra-partum stillbirths (z=2 57; P=0 003) and first-week neonatal deaths (z=2-84; P=0-0025) was seen. The major factor contributing to the improvement in perinatal mortality was monitoring of the premature fetus (table III) . This improvement was evident during both the intra-partum and neonatal periods. Three monitors were enough for about 1000 patients, and a close liaison with our medical physics department ensured that breakdowns were dealt with without having to send the monitors away for repair. The assessment of the value of any new technique is always complicated by the difficulty of controlling the many variables that may influence the final outcome. Changes in clinical policies, such as induction, and in the composition of the obstetric population may be powerful influences on perinatal mortality which are independent of monitoring. Nevertheless, our results are encouraging, suggesting as they do that total monitoring by improved surveillance added to the safety of the fetus during labour; the reduction in fetal mortality is a strong argument in support of this view. Until recently it has been argued that the cost of introducing monitoring as a routine practice could not be justified in Britain. But as the whole objective of pregnancy is to produce a healthy baby the cost of equipping obstetric units throughout Britain with monitors seems small in comparison with the benefit that is likely to result from such a policy.
